Education
About Us
Working with TipRanks
Follow Us
Glaukos (GKOS)
NYSE:GKOS
Earnings Data
Report Date
Feb 19, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.21Last Year’s EPS
-0.4Same Quarter Last Year
Strong Buy
Based on 12 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Glaukos showcased strong financial performance with record sales and significant product approvals, particularly the FDA approval of Epioxa. However, the company faces challenges with transitioning its Corneal Health franchise and establishing market access for new products.Company Guidance
Record Third Quarter Sales
Glaukos reported record third quarter consolidated net sales of $133.5 million, up 38% on a reported basis or 37% on a constant currency basis versus the year-ago quarter.
iDose TR Adoption
The U.S. Glaucoma franchise delivered record third quarter net sales of $80.8 million, with iDose TR generating sales of approximately $40 million in the third quarter.
Epioxa FDA Approval
FDA approved Epioxa for corneal cross-linking for keratoconus, marking a significant milestone as the first and only FDA-approved topical drug therapy that does not require the removal of the corneal epithelium.
Raised Full-Year 2025 Guidance
Full-year 2025 net sales guidance raised to $490 million to $495 million from $480 million to $486 million.
Strong International Growth
International Glaucoma franchise net sales of $29.4 million, marking a year-over-year growth of 20% on a reported basis and 17% on a constant currency basis.
GKOS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GKOS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 29, 2025 | $77.09 | $87.80 | +13.89% |
Jul 30, 2025 | $94.05 | $86.09 | -8.46% |
Apr 30, 2025 | $94.25 | $83.54 | -11.36% |
Feb 20, 2025 | $157.36 | $125.88 | -20.01% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Glaukos (GKOS) report earnings?
Glaukos (GKOS) is schdueled to report earning on Feb 19, 2026, After Close (Confirmed).
What is Glaukos (GKOS) earnings time?
Glaukos (GKOS) earnings time is at Feb 19, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GKOS EPS forecast?
GKOS EPS forecast for the fiscal quarter 2025 (Q4) is -0.21.